NCT02329860
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
- Jiangsu hengrui medicine CO. LTD Lianyungang, Jiangsu, China
Clinical trial condition
Adenocarcinoma
Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.
5,051 public trials
1,181 recruiting studies
Adenocarcinoma trial results
NCT00804128
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT03535259
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
- Locations
-
- Bo Chen Beijing, Beijing Municipality, China
NCT04134390
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
- Locations
-
- Hospital de Ciudad Real Ciudad Real, Spain
- ICO L'Hospitalet L'Hospitalet de Llobregat, Spain
- Hospital Insular de Gran Canarias Las Palmas de Gran Canaria, Spain
- Hospital Lucus Augusti Lugo, Spain
NCT01004978
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
NCT00486356
- Conditions
- Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +23 more
- Locations
-
- University of Nebraska Medical Center, Eppley Cancer Center Omaha, Nebraska, United States
NCT00719966
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT01825603
- Conditions
- Adenocarcinoma, Ampulla of Vater Adenocarcinoma, Biliary Tract Diseases, +35 more
- Locations
-
- University of Nebraska Medical Center Omaha, Nebraska, United States
NCT02399215
- Conditions
- Adenocarcinoma, Carcinoid Tumor, Carcinoma, +9 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Completed
Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors
NCT01709435
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +30 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Children's Hospital of Orange County Orange, California, United States
- UCSF Medical Center-Parnassus San Francisco, California, United States
- UCSF Medical Center-Mission Bay San Francisco, California, United States